DBCO-PEG4-VC-PAB-DMEA-PNU159682 - CAS 2259318-56-2

DBCO-PEG4-VC-PAB-DMEA-PNU159682 - CAS 2259318-56-2 Catalog number: BADC-00762

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

DBCO-PEG4-VC-PAB-DMEA-PNU159682 is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via DBCO-PEG4-VC-PAB-DMEA.

Category
ADCs Cytotoxin with Linkers
Product Name
DBCO-PEG4-VC-PAB-DMEA-PNU159682
CAS
2259318-56-2
Catalog Number
BADC-00762
Molecular Formula
C86H106N10O26
Molecular Weight
1695.84
DBCO-PEG4-VC-PAB-DMEA-PNU159682

Ordering Information

Catalog Number Size Price Quantity
BADC-00762 -- $-- Inquiry
Description
DBCO-PEG4-VC-PAB-DMEA-PNU159682 is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via DBCO-PEG4-VC-PAB-DMEA.
Synonyms
DBCO-PEG4-VC-PAB-DMEA-PNU-159682
Shipping
Room temperature, or blue ice upon request.
Storage
-20°C

DBCO-PEG4-VC-PAB-DMEA-PNU159682 is a complex bioconjugation reagent often used in drug delivery and molecular targeting applications. Here are some key applications of DBCO-PEG4-VC-PAB-DMEA-PNU159682:

Targeted Drug Delivery: DBCO-PEG4-VC-PAB-DMEA-PNU159682 can be utilized to deliver therapeutic molecules specifically to cancer cells. By conjugating this reagent to an antibody or other targeting moiety, it can bind selectively to tumor-specific markers. This ensures that the attached drug is released primarily at the site of the tumor, minimizing off-target effects and improving therapeutic efficacy.

Prodrug Activation: This reagent is employed in the design of prodrugs, which are inactive precursors of drugs that become activated in the body. The linkage in DBCO-PEG4-VC-PAB-DMEA-PNU159682 can be cleaved in the tumor microenvironment, releasing the active drug PNU159682. This strategy enhances the drug’s concentration at the desired site while reducing systemic toxicity.

Bioconjugation Research: DBCO-PEG4-VC-PAB-DMEA-PNU159682 is a valuable tool in bioconjugation studies. It allows for the attachment of various biomolecules, such as peptides, proteins, and nucleic acids, through click chemistry reactions. This facilitates the exploration of new therapeutic constructs and diagnostic agents with precise molecular architecture.

Therapeutic Antibody Development: In the field of therapeutic antibody development, DBCO-PEG4-VC-PAB-DMEA-PNU159682 is vital for creating antibody-drug conjugates (ADCs). These conjugates combine the targeting ability of antibodies with the potency of cytotoxic drugs. By ensuring a stable and specific linkage, this reagent helps in generating ADCs that can target and kill cancer cells effectively.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket